Bmtcn chapter 6 Study guides, Class notes & Summaries
Looking for the best study guides, study notes and summaries about Bmtcn chapter 6? On this page you'll find 34 study documents about Bmtcn chapter 6.
Page 2 out of 34 results
Sort by
-
BMTCN Review Chapter 7 - Survivorship Issues fully solved rated A+
- Exam (elaborations) • 22 pages • 2023
- Available in package deal
-
- $19.99
- + learn more
BMTCN Review Chapter 7 - Survivorship IssuesSurvivors and Survivorship - correct answer An individual is considered a cancer survivor from the time of diagnosis through the balance of his/her life 
 
Survivorship is a distinct phase of the cancer experience 
 
Some patients do not embrace the term "cancer survivor" 
 
Some definitions acknowledge the impact of cancer survivorship on families, friends and caregivers 
 
HSCT Survivorship - correct answer Number is increasing 
-Improvements in ou...
-
BMTCN Chapter 5: Graft-versus-Host Disease Q&A
- Exam (elaborations) • 10 pages • 2024
-
Available in package deal
-
- $7.99
- + learn more
BMTCN Chapter 5: Graft-versus-Host 
Disease 
T.R. is a 28-year-old woman with acute myeloid leukemia in her second complete 
remission who is admitted for a matched unrelated allogeneic stem cell transplantation. 
Her conditioning regimen is as follows: 
Myeloablation (busulfan/cyclophosphamide) and immunosuppression with tacrolimus 
and methotrexate (5 mg/m2 on days +1, +3, +6, and +11). 
She did not receive methotrexate on day +11 because of severe mucositis. Her 
transplant course was complic...
-
BMTCN Chapter 5 Graft-versus-Host Disease Question and answers 100% correct 2023/2024
- Exam (elaborations) • 12 pages • 2023
-
Available in package deal
-
- $13.49
- + learn more
BMTCN Chapter 5 Graft-versus-Host Disease Question and answers 100% correct 2023/2024T.R. is a 28-year-old woman with acute myeloid leukemia in her second complete remission who is admitted for a matched unrelated allogeneic stem cell transplantation. Her conditioning regimen is as follows: 
 
Myeloablation (busulfan/cyclophosphamide) and immunosuppression with tacrolimus and methotrexate (5 mg/m2 on days +1, +3, +6, and +11). 
 
She did not receive methotrexate on day +11 because of severe muc...
-
BMTCN Chapter 6: Post-Transplant Issues Questions & Answers Solved 100% Correct!!
- Exam (elaborations) • 17 pages • 2023
- Available in package deal
-
- $8.49
- + learn more
Which of the following is NOT an identified risk factor associated with infection? 
A. Personal history of infection 
B. Type of transplantation (autologous or allogeneic) 
C. Myeloablative transplant 
D. None of the above -Answer D. None of the above 
Clostridium difficile is not a common infection in the post-transplant setting. 
A. True 
B. False -Answer B. False 
A cord blood transplantation is associated with all of the following EXCEPT: 
A. Prolonged neutrophil and immune recovery 
B. Incr...
-
BMTCN Chapter 6 Post-Transplant Issues ;Questions and Answers , 100% Correct, Download to Score A
- Exam (elaborations) • 11 pages • 2024
-
- $7.99
- + learn more
BMTCN Chapter 6 Post-Transplant Issues ;Questions and Answers , 100% Correct, Download to Score A
Make study stress less painful
-
BMTCN - Chapter 6 question n answers graded A+ verified to pass 2023/2024
- Exam (elaborations) • 8 pages • 2023
- Available in package deal
-
- $14.99
- + learn more
BMTCN - Chapter 6What are the types of cardiac diseases common post HSCT? What conditioning medications can cause these diseases? - correct answer Cardiomyopathy, arrhythmias, congestive heart failure - high dose Cytoxan and radiation causes this 
 
HTN/Dyslipidemia: Immunosuppression meds 
 
HTN/Hyperkalemia: Cyclosporine 
 
HTN/Hyperlipidemia and edema: Sirolimus 
 
How would you management cardiac disease in post-HSCT patients? - correct answer Assess risk factors, follow up testing (EKG, ...
-
BMTCN Chapter 5 Graft-versus-Host Disease correctly answered rated A+ 2023/2024
- Exam (elaborations) • 12 pages • 2023
- Available in package deal
-
- $17.99
- + learn more
BMTCN Chapter 5 Graft-versus-Host DiseaseT.R. is a 28-year-old woman with acute myeloid leukemia in her second complete remission who is admitted for a matched unrelated allogeneic stem cell transplantation. Her conditioning regimen is as follows: 
 
Myeloablation (busulfan/cyclophosphamide) and immunosuppression with tacrolimus and methotrexate (5 mg/m2 on days +1, +3, +6, and +11). 
 
She did not receive methotrexate on day +11 because of severe mucositis. Her transplant course was complicated...
-
BMTCN Review Chapter 2-Types of Transplants and Sources of Stem Cells Question and answers correctly solved 2023/2024
- Exam (elaborations) • 3 pages • 2023
-
Available in package deal
-
- $14.49
- + learn more
BMTCN Review Chapter 2-Types of Transplants and Sources of Stem Cells Question and answers correctly solved 2023/2024Types of SCT (3) - correct answer -Allogeneic 
-Syngeneic 
-Autologous 
 
Stem Cell Sources (3) - correct answer -Peripheral Blood (PBSCT) 
-Bone Marrow 
-Umbilical Cord (UCB) 
 
Specific Types of Allogeneic Transplant (6) - correct answer -Syngeneic 
-Matched sibling/related 
-Mismatch related 
-Matched unrelated 
-Mismatched unrelated 
-Umbilical cord 
 
Syngeneic 
(source, adva...
-
BMTCN - Chapter 6 questions well answered graded A+ 2023/2024
- Exam (elaborations) • 8 pages • 2023
- Available in package deal
-
- $14.99
- + learn more
BMTCN - Chapter 6What are the types of cardiac diseases common post HSCT? What conditioning medications can cause these diseases? - correct answer Cardiomyopathy, arrhythmias, congestive heart failure - high dose Cytoxan and radiation causes this 
 
HTN/Dyslipidemia: Immunosuppression meds 
 
HTN/Hyperkalemia: Cyclosporine 
 
HTN/Hyperlipidemia and edema: Sirolimus 
 
How would you management cardiac disease in post-HSCT patients? - correct answer Assess risk factors, follow up testing (EKG, ...
-
BMTCN Chapter 5 Graft-versus-Host Disease fully solved graded A+
- Exam (elaborations) • 12 pages • 2023
- Available in package deal
-
- $17.99
- + learn more
BMTCN Chapter 5 Graft-versus-Host DiseaseT.R. is a 28-year-old woman with acute myeloid leukemia in her second complete remission who is admitted for a matched unrelated allogeneic stem cell transplantation. Her conditioning regimen is as follows: 
 
Myeloablation (busulfan/cyclophosphamide) and immunosuppression with tacrolimus and methotrexate (5 mg/m2 on days +1, +3, +6, and +11). 
 
She did not receive methotrexate on day +11 because of severe mucositis. Her transplant course was complicated...
Study stress? For sellers on Stuvia, these are actually golden times. KA-CHING! Earn from your study resources too and start uploading now. Discover all about earning on Stuvia